The Presidential Commission for the Study of Bioethical Issues, a government advisory panel, released a statement reinforcing the need for privacy protection for those who choose to submit their whole genome sequencing for the purpose of medical research. Genomes...
FierceBiotech has compiled a list of the 20 top pharma-academic collaborations from 2012 which can be found here. This list notes the Big Pharma players who have collaborated with universities and academic medical centers and gone above and beyond typical research...
In a recent article from Outsourcing-pharma.com, the Association of Clinical Research Organization (ACRO) is voicing their opinion on the misrepresentation of trial participants as test monkeys. The VP of ACRO, John Lewis made sure to note that research trial...
While there are many different size clinical research sites, competition becomes increasingly difficult for smaller sites with smaller amounts of employees, resources, etc.. In a recent article written by Gina Nesbit, a hypothetical site is created, Acme Research,...
Although the elderly are often considered ineligible for clinical trials, experts in a recent article from Outsourcing-pharma.com are saying the age group “must be taken into consideration more often during research.” Clinical trials are intended to be...
Effective September 26,2012 Health and Human Services has assigned responsibility to FDA for enforcing reporting by sponsors on ClinicalTrials.gov. Based on a notice by the Federal Register, FDA is now responsible for keeping track of the database’s most recent...
